CIK 0001080014
- Large accelerated filer
Innoviva, Inc.
Sign in to watch- Ticker
- INVA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943265960
- Phone
- +1 650-238-9600
- Business address
- 1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
- Former names
- THERAVANCE INC, ADVANCED MEDICINE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-06-02 | Aguiar Michael W Sr VP, Chief Financial Officer | Grant or award | +21,000 | 216,570 | ||
| 2014-05-22 | YOUNG WILLIAM D Director | Grant or award | +6,000 | 83,935 | ||
| 2014-05-22 | YOUNG WILLIAM D Director | Grant or award · Stock Option (Right to Buy) | +6,000 | 6,000 | ||
| 2014-05-22 | WHITESIDES GEORGE M Director | Grant or award | +6,000 | 606,377 | ||
| 2014-05-22 | WHITESIDES GEORGE M Director | Grant or award · Stock Option (Right to Buy) | +6,000 | 6,000 | ||
| 2014-05-22 | WALTRIP WILLIAM H Director | Grant or award | +6,000 | 100,064 | ||
| 2014-05-22 | WALTRIP WILLIAM H Director | Grant or award · Stock Option (Right to Buy) | +6,000 | 6,000 | ||
| 2014-05-22 | RINGROSE PETER S Director | Grant or award | +6,000 | 36,000 | ||
| 2014-05-22 | RINGROSE PETER S Director | Grant or award · Stock Option (Right to Buy) | +6,000 | 6,000 | ||
| 2014-05-22 | MALKIEL BURTON G Director | Grant or award | +6,000 | 41,000 | ||
| 2014-05-22 | MALKIEL BURTON G Director | Grant or award · Stock Option (Right to Buy) | +6,000 | 6,000 | ||
| 2014-05-22 | Gunderson Robert V JR Director | Grant or award | +6,000 | 115,970 | ||
| 2014-05-22 | Gunderson Robert V JR Director | Grant or award · Stock Option (Right to Buy) | +6,000 | 6,000 | ||
| 2014-05-22 | Fore Henrietta Director | Grant or award | +6,000 | 33,000 | ||
| 2014-05-22 | Fore Henrietta Director | Grant or award · Stock Option (Right to Buy) | +6,000 | 6,000 | ||
| 2014-05-09 | GLAXOSMITHKLINE PLC 10% owner | Purchase | +317,770 | $8,544,835.30 | $2715.3B | 30,576,072 |
| 2014-05-09 | Winningham Rick E Chief Executive Officer | Shares withheld for taxes | −50,225 | $26.86 | $1.3M | 703,038 |
| 2014-05-09 | Shafer Bradford J Sr VP, Gen. Counsel, Secretary | Shares withheld for taxes | −22,833 | $26.86 | $613K | 341,398 |
| 2014-05-09 | Mammen Mathai SVP, Research & Early Clin Dev | Shares withheld for taxes | −22,833 | $26.86 | $613K | 239,136 |
| 2014-05-09 | LEE JUNNING Sr. VP, Technical Operations | Shares withheld for taxes | −14,650 | $26.86 | $393K | 159,887 |
Page 21 of 23 · 446 trades